You are here: Home » PTI Stories » National » News
Business Standard

Suven Life gets patent from New Zealand for neurological drug

Press Trust of India  |  New Delhi 

firm has received a patent from for a used for treatment of neuro-degenerative diseases.

In a filing today, Suven Life said it has been granted "one product patent from corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with neuro-degenerative diseases".

The patents are valid till 2034, the company added.

Suven Life CEO said: "We are very pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS arena, which are being developed for cognitive disorders with high unmet medical need with a huge market potential globally."

stock was trading 6.08 per cent up at Rs 192 on the in the morning trade.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

First Published: Tue, October 10 2017. 11:42 IST